Orexin-A protects against cerebral ischemia-reperfusion injury by inhibiting excessive autophagy through OX1R-mediated MAPK/ERK/mTOR pathway.

Cellular Signalling
Dandan XuChunmei Wang

Abstract

Orexin A (OXA) is a neuroprotective peptide that exerts protective effects on multiple physiological and pathological processes. Activation of autophagy is linked to the occurrence of cerebral ischemia-reperfusion injury (CIRI); however, its function remains incompletely understood. In this study, OXA was sought to exert its neuroprotective role by regulating autophagy in oxygen and glucose deprivation and reoxygenation (OGD/R) model and middle cerebral artery occlusion (MCAO) model of rats, and to elucidate the underlying molecular mechanisms. Acridine orange (AO) staining was used to evaluate autophagic vacuoles. Cell viability was measured by CCK8. The levels of p-ERK1/2, t-ERK1/2, p-mTOR, LC3B, Beclin 1, and p62 were evaluated by western blotting. Apoptosis rate was detected by Hoechst 33342 staining and Terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling (TUNEL). OXA treatment alleviated neuronal apoptosis and significantly inhibited autophagy activity. Mechanistically, OXA exerted its neuroprotective effects in vivo and in vitro by suppressing over-activated autophagy by modulating OX1R-mediated MAPK/ERK/mTOR pathway. The results of this study elucidate the roles of autophagy in CIRI and the mechanisms un...Continue Reading

References

Aug 23, 2003·Cell Death and Differentiation·E H Baehrecke
Apr 8, 2004·Developmental Cell·Beth Levine, Daniel J Klionsky
Apr 23, 2004·Trends in Cell Biology·Ana Maria Cuervo
Nov 6, 2004·Science·Takahiro Shintani, Daniel J Klionsky
Feb 29, 2008·Nature·Noboru MizushimaDaniel J Klionsky
Apr 1, 2008·Journal of Gastroenterology·Mehmet BülbülV Nimet Izgüt-Uysal
Apr 17, 2012·Cell·Mathieu Laplante, David M Sabatini
Jan 5, 2013·Cancer Research·Tomonori KimuraYoshitaka Isaka
Aug 17, 2014·Experimental Cell Research·Jin-Hwan KimJong-In Park
Jan 25, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Eleni VergadiChristos Tsatsanis
May 12, 2018·Stroke; a Journal of Cerebral Circulation·Masakazu KotodaTomoki Hashimoto
Jul 10, 2018·International Journal of Immunopathology and Pharmacology·Chun-Mei WangBo Bai
Jul 6, 2019·The Journal of Surgical Research·Baochuan LiYunsheng Li
Jul 22, 2019·Translational Stroke Research·Zohi Sternberg, B Schaller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis